Review on lipegfilgrastim
Authors:
Open Access
- 1 November 2015
- journal article
- editorial
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 10, 6863-6864
Abstract
Review on lipegfilgrastim Maja Gasparic, Sophie Leyman Teva Pharmaceuticals Europe BV, European Headquarters, Amsterdam, the NetherlandsHaving read the original Hoggatt et al article1 and the corrigendum published online on August 27, 2015,2 we do not consider the description of lipegfilgrastim to be entirely accurate, and we would therefore like to clarify what lipegfilgrastim actually is.The description of lipegfilgrastim used in the original article was a âKeywords
This publication has 2 references indexed in Scilit:
- Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]International Journal of Nanomedicine, 2015
- Role of lipegfilgrastim in the management of chemotherapy-induced neutropeniaInternational Journal of Nanomedicine, 2015